X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8927) 8927
Newspaper Article (1953) 1953
Publication (838) 838
Web Resource (425) 425
Trade Publication Article (308) 308
Report (185) 185
Book Review (178) 178
Book Chapter (164) 164
Magazine Article (61) 61
Conference Proceeding (23) 23
Book / eBook (10) 10
Dissertation (6) 6
Government Document (5) 5
Paper (4) 4
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6665) 6665
index medicus (4195) 4195
female (3513) 3513
male (3498) 3498
initial public offerings (2970) 2970
initial treatment (2919) 2919
middle aged (2635) 2635
adult (2331) 2331
aged (2027) 2027
treatment outcome (2016) 2016
oncology (1318) 1318
initial-experience (1006) 1006
care and treatment (962) 962
cancer (956) 956
therapy (956) 956
surgery (943) 943
retrospective studies (872) 872
initial therapy (795) 795
aged, 80 and over (791) 791
gastroenterology & hepatology (791) 791
adolescent (787) 787
clinical trials (769) 769
radiology, nuclear medicine & medical imaging (741) 741
hematology (737) 737
risk factors (729) 729
infectious diseases (725) 725
pharmacology & pharmacy (712) 712
drug therapy, combination (680) 680
randomized-trial (674) 674
medicine, general & internal (635) 635
analysis (633) 633
follow-up studies (621) 621
double-blind (604) 604
hepatitis c, chronic - drug therapy (603) 603
research (600) 600
drug therapy (599) 599
antiviral agents - therapeutic use (591) 591
prognosis (586) 586
time factors (580) 580
pharmaceutical industry (576) 576
health aspects (542) 542
prospective studies (540) 540
child (538) 538
animals (533) 533
patients (527) 527
medicine & public health (510) 510
diagnosis (508) 508
clinical neurology (507) 507
management (490) 490
recombinant proteins (466) 466
young adult (464) 464
cardiac & cardiovascular systems (436) 436
chemotherapy (434) 434
interferon-alpha - therapeutic use (434) 434
abridged index medicus (432) 432
follow-up (428) 428
investments (422) 422
hepatitis c (416) 416
ribavirin - therapeutic use (414) 414
ribavirin (399) 399
survival (398) 398
trial (396) 396
acquisitions & mergers (395) 395
combination therapy (394) 394
efficacy (390) 390
hiv infections - drug therapy (383) 383
recurrence (381) 381
mortality (377) 377
biotechnology industry (370) 370
plus ribavirin (370) 370
immunology (368) 368
usage (358) 358
radiotherapy (355) 355
research & development--r&d (355) 355
virology (355) 355
antineoplastic combined chemotherapy protocols - therapeutic use (354) 354
peripheral vascular disease (354) 354
article (350) 350
net losses (338) 338
virus-infection (336) 336
children (334) 334
combination (327) 327
hepacivirus - genetics (327) 327
infection (326) 326
genotype (325) 325
initial validation (324) 324
interferon (324) 324
pediatrics (324) 324
disease (322) 322
tumors (321) 321
randomized controlled trials as topic (320) 320
medical research (318) 318
child, preschool (311) 311
psychiatry (303) 303
going public (297) 297
interferon-alpha-2b plus ribavirin (294) 294
randomized controlled-trial (294) 294
viral load (291) 291
studies (290) 290
combined modality therapy (286) 286
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (3) 3
Gerstein Science - Stacks (2) 2
UofT at Mississauga - Stacks (2) 2
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11573) 11573
German (175) 175
French (113) 113
Spanish (58) 58
Japanese (32) 32
Russian (18) 18
Korean (17) 17
Turkish (7) 7
Polish (5) 5
Croatian (4) 4
Czech (4) 4
Italian (4) 4
Portuguese (2) 2
Chinese (1) 1
Hungarian (1) 1
Persian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 09/2011, Volume 365, Issue 11, pp. 993 - 1003
In patients with a recent transient ischemic attack or stroke attributed to 70 to 99% stenosis of a major intracranial artery, aggressive medical management... 
MEDICINE, GENERAL & INTERNAL | INITIAL-EXPERIENCE | ATHEROSCLEROSIS | RESTENOSIS | PATTERNS | RISK | RECURRENT STROKE | ATHEROMATOUS DISEASE | WINGSPAN STENT | ISCHEMIC-STROKE | BLOOD-PRESSURE | Intracranial Arteriosclerosis - drug therapy | Stroke - prevention & control | Ischemic Attack, Transient - drug therapy | Ischemic Attack, Transient - therapy | Follow-Up Studies | Ticlopidine - therapeutic use | Humans | Middle Aged | Intracranial Hemorrhages - etiology | Kaplan-Meier Estimate | Male | Combined Modality Therapy | Antihypertensive Agents - therapeutic use | Health Behavior | Ticlopidine - analogs & derivatives | Stroke - etiology | Intracranial Hemorrhages - epidemiology | Female | Aged | Aspirin - therapeutic use | Intracranial Arteriosclerosis - therapy | Platelet Aggregation Inhibitors - therapeutic use | Stents - adverse effects | Stroke - therapy | Stroke (Disease) | Treatment outcome | Usage | Care and treatment | Angioplasty | Causes of | Stenosis | Health aspects | Stent (Surgery) | Arteries | Transient ischemic attack | Funding | Exercise | Ischemia | Implants | Blood pressure | Drug dosages | Neurological disorders | Stroke | Territory | Aspirin | Medical imaging | FDA approval | Management | Patients | Cholesterol | Neurological diseases | Studies | Physical fitness | Arteriosclerosis | Death | Lifestyles | Diabetes | Clinical medicine | Veins & arteries
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2014, Volume 371, Issue 10, pp. 895 - 905
In patients 65 or younger with multiple myeloma, high-dose consolidation therapy was associated with longer survival and more myelotoxicity than... 
MEDICINE, GENERAL & INTERNAL | PREDNISONE | PLUS DEXAMETHASONE | INDUCTION THERAPY | LENALIDOMIDE | INITIAL TREATMENT | RANDOMIZED CONTROLLED-TRIAL | BORTEZOMIB | STEM-CELL TRANSPLANTATION | ELDERLY-PATIENTS | MELPHALAN | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Multiple Myeloma - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Transplantation, Autologous | Consolidation Chemotherapy | Antineoplastic Agents, Alkylating - administration & dosage | Thalidomide - analogs & derivatives | Multiple Myeloma - drug therapy | Multiple Myeloma - therapy | Melphalan - adverse effects | Adult | Maintenance Chemotherapy | Neutropenia - chemically induced | Thalidomide - adverse effects | Prednisone - administration & dosage | Prednisone - adverse effects | Kaplan-Meier Estimate | Combined Modality Therapy | Thalidomide - administration & dosage | Disease-Free Survival | Melphalan - administration & dosage | Aged | Antineoplastic Agents, Alkylating - adverse effects | Stem Cell Transplantation - adverse effects | Complications and side effects | Care and treatment | Patient outcomes | Multiple myeloma | Stem cells | Transplantation | Research | Health aspects | Autografts | Chemotherapy | Cell survival | Transplants & implants | Melphalan | Stem cell transplantation | Death | Prednisone | Drug dosages | Neutropenia | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Radiotherapy and Oncology, ISSN 0167-8140, 2014, Volume 112, Issue 1, pp. 9 - 16
Journal Article
Journal Article
Journal Article
Hepatology, ISSN 0270-9139, 11/2002, Volume 36, Issue 5B, pp. s121 - s127
Journal Article